| Title : NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity - Moecking_2021_J.Allergy.Clin.Immunol_147_2134 |
| Author(s) : Moecking J , Laohamonthonkul P , Chalker K , White MJ , Harapas CR , Yu CH , Davidson S , Hrovat-Schaale K , Hu D , Eng C , Huntsman S , Calleja DJ , Horvat JC , Hansbro PM , O'Donoghue RJJ , Ting JP , Burchard EG , Geyer M , Gerlic M , Masters SL |
| Ref : J Allergy Clin Immunol , 147 :2134 , 2021 |
| Abstract : Moecking_2021_J.Allergy.Clin.Immunol_147_2134 |
| ESTHER : Moecking_2021_J.Allergy.Clin.Immunol_147_2134 |
| PubMedSearch : Moecking_2021_J.Allergy.Clin.Immunol_147_2134 |
| PubMedID: 33378691 |
Moecking J, Laohamonthonkul P, Chalker K, White MJ, Harapas CR, Yu CH, Davidson S, Hrovat-Schaale K, Hu D, Eng C, Huntsman S, Calleja DJ, Horvat JC, Hansbro PM, O'Donoghue RJJ, Ting JP, Burchard EG, Geyer M, Gerlic M, Masters SL (2021)
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity
J Allergy Clin Immunol
147 :2134
Moecking J, Laohamonthonkul P, Chalker K, White MJ, Harapas CR, Yu CH, Davidson S, Hrovat-Schaale K, Hu D, Eng C, Huntsman S, Calleja DJ, Horvat JC, Hansbro PM, O'Donoghue RJJ, Ting JP, Burchard EG, Geyer M, Gerlic M, Masters SL (2021)
J Allergy Clin Immunol
147 :2134